AVEVA Buprenorphine Patch Recall: Impurities Risk Serious Harm

Take action

Contact the company & request your remedy

Recalling firmAVEVA Drug Delivery Systems, Inc.3250 Commerce Pkwy, N/A · Miramar, FL 33025-3907

No email on file — write to the address above instead.

✎ GovInfoNow plain-language explainer

What happened, in plain English

AVEVA recalls 4-pack buprenorphine patches (CIII 10 mcg/hour) because impurities were found at 18 months. This could cause serious health risks if used without proper quality control.

Why it’s dangerous

The patches contain impurities (10-hydroxy buprenorphine N-Oxide) that exceed safe levels after 18 months. This could lead to serious health effects if the impurities interact with the body.

Who’s affected

Prescription users of the 4-pack buprenorphine patches with NDC 60505-7077-05, lot 51835 (expiring June 2023). People using these patches for opioid addiction treatment are most at risk.

How to tell if you have this one

Check for the NDC code 60505-7077-05 and lot number 51835 on the packaging. The product expires June 2023 and is a prescription-only 4-pack of buprenorphine patches.

Brand
AVEVA
Category
Drug

Based on the official FDA remedy

What to do — step by step

Stop Using Now
Immediately discard the recalled buprenorphine patches as they contain impurities that could cause serious health risks.

✎ GovInfoNow

Questions people ask

Why is this patch being recalled?

The patches contain impurities (10-hydroxy buprenorphine N-Oxide) that exceed safe levels after 18 months of storage.

What should I do if I have this patch?

Discard the entire package immediately as the remedy requires stopping use.

Is this patch safe to use?

No, the impurities found at 18 months could cause serious health risks, so it should not be used.

Take action

Contact AVEVA

We’ve drafted a message you can send AVEVA to request your refund or repair — edit it as you like.

✉️ Open in email

Subject: Recall D-0465-2023 — AVEVA AVEVA

Hello,

I own a AVEVA that is covered by recall D-0465-2023 from AVEVA.

I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this?

Thank you.

Similar recalls

From people who’ve dealt with this

Experiences, tips, and questions from readers. Every comment is reviewed before it appears.

No comments yet — be the first to share your experience.

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

Official source: FDA Recall #D-0465-2023 (February 15, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0465-2023 to see it in context.
Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.

AVEVA Drug Delivery Systems, Inc. recalls Buprenorphine Transdermal System, CIII 10 mcg/hour, 4 Transdermal Systems One package of 4 disposal units, Rx Only,

Stop using this now